The 2023 Georgia Life Science Summit is Nov. 1, 2023

The state’s premier life sciences gathering for over three decades, Georgia Bio proudly presents the 2023 Georgia Life Science Summit on Wednesday, November 1, 2023 at the Sandy Springs Arts Center.

Dr. Ted W. Love headshot

The 2023 summit, more concentrated in scope yet expansive in industry inclusion, will be Wednesday, November 1st at the Sandy Springs Arts Center. The program is coming along nicely including a recently secured keynote address and chat featuring Dr. Ted W. Love , former President and CEO of Global Blood Therapeutics and 2023-2025 Chair of the Board of the Biotechnology Innovation Organization (BIO).

Other program elements including speakers / presenters currently include:

  • Patricia Obermaier, Chief Growth Officer, Global Health and Life Sciences, Microsoft
  • Dr. Joe Sutherland, Director, Center for AI Learning, Emory University
  • The Intersection of Software and Science – A Plenary Session
  • Launching and Funding a Company in a Challenging Environment: Investors’ Perspectives of Best Practices and Critical Errors – A Plenary Session
  • Life Sciences Showcase – Hear Georgia-based companies who are developing or have bioscience/medtech related products present their technology. (Winners announced during the closing session)
  • Plenty of dedicated networking time and a closing reception with light food and beverages.

We encourage you to join us in reconnecting with the life science industry ecosystem. 

Learn more and register here .

In the meantime, please know we are working diligently and with strong industry support to accomplish the following: rebuild trust with industry, strengthen brand awareness, simplify our message and respond to industry demand for a stronger unified voice on behalf of industry for policy priorities.

“Georgia Bio is recommitting to its core mission of advocating for, connecting, educating and inspiring our member enterprises and stakeholders in much the same way our colleagues have known Georgia Bio since its inception in 1989,” Georgia Bio CEO Maria Thacker said. “We will now do that through an industry-wide lens more inclusive of new medical technologies and devices, and food and ag innovations. We expect the 2023 Summit to be a high value, enthusiastic event for all of our participants and stakeholders.”

By Maria Thacker Goethe April 18, 2025
The Science & Community Impacts Mapping Project (SCIMaP) shows how proposed federal funding cuts lead to reduced economic activity and job losses nationwide.
By Sheran Brown April 10, 2025
Georgia Life Sciences Selects Fulton County Schools Innovation Academy Student as the 2025 Georgia BioGENEius Winner Sandy Springs & Rockmart Teens Take Top Honors in Statewide Science Competition Atlanta, GA (April 4, 2025) – Georgia Life Sciences today named Bhavya Alapati , a junior at Fulton County Schools Innovation Academy, as the winner of the 2025 Georgia BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in the biotechnology field. Eleven students from across Georgia competed for this year’s title and cash prize. Bhavya’s project investigated a novel method of identifying strokes using a device she created called SpectroStroke, a small-scale spectrophotometer, to detect homocysteine, an amino acid product that is associated with stroke. Bhavya identified the ability of homocysteine to be detected using Ellman’s reagent, which reacts with the free sulfhydryl group on the molecule to produce a yellow color. Bhavya created a wearable patch that contains the Ellman’s reagent. Then, she designed the SpectroStroke to be able to detect the color change when the patch is exposed to elevated levels of homocysteine. Bhavya’s SpectroStroke can detect normal levels of homocysteine up to extremely high levels seen in those experiencing a stroke. The ability to detect a stroke earlier would reduce damage and long-term effects of the condition. A future iteration of the SpectroStroke would include real-time monitoring capabilities to help track changing homocysteine levels. "Supporting and celebrating outstanding research and innovation in biotechnology is vital for the future of science and medicine. The Georgia BioGENEius Challenge not only encourages the brightest young minds to explore their potential but also nurtures the next generation of leaders who will drive groundbreaking advancements in biotechnology,” said Georgia Life Sciences President and CEO Maria Thacker-Goethe. “By recognizing and empowering these students, we are helping to shape a future where innovation thrives and the possibilities for improving lives are endless. Well done, Bhavya!” Georgia Life Sciences also congratulates the Georgia BioGENEius runner-up, Shelby Kendrick , who is a senior at Paulding County High School in Dallas, GA. Shelby’s research investigated the ability of Aspergillus terreus, a fungus found in soil, to degrade pre-treated polypropylene plastic (PP). This fungus has been discovered to produce high concentrations of degrading enzymes and raises the moisture level of its substrate. Shelby isolated the fungus from soil samples and confirmed the species using PCR amplification and DNA barcoding. Samples of polypropylene were pre-treated with 75% ethanol and UV exposure, then placed in a liquid culture of A. terreus in Minimal Salt Medium (MSM) media, and the culture was incubated for 23 days. At the end of the trial period, PP samples were analyzed using Scanning Electron Microscopy. These samples showed changes in their surface layer, indicating evidence of biodegradation. Polypropylene plastic is found in household items such as plastic cups and is a known problem in the environment due to its inability to degrade. Shelby’s future research on the use of A. terreus for biodegradation includes optimizing degradation conditions and assessing methods of application in the environment. Judging the 2025 Georgia BioGENEius Challenge were Ralph L. Cordell, CDC, and Alex Harvey, ViaMune. Cash prizes were awarded to Bhavya and Shelby. # # # About Georgia Life Sciences Georgia Life Sciences, founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. It is the state’s largest and most influential life sciences advocacy and business leadership organization working to improve access to innovative discoveries that have lifesaving impact. The association connects business, academia, government, and other allied entities involved in the application of life sciences products to fuel growth and collaboration through policy development, community programs, national industry initiatives, and a portfolio of educational and networking events. Learn more at galifesciences.org.
By Maria Thacker Goethe April 9, 2025
Emerging biotechnology is key for U.S. to remain dominant and secure future economic growth in a new era of global competition
MORE POSTS